We are live on ! Find out more
VU

Valence8 US Portfolio holdings

AUM $286M
1-Year Est. Return 22.37%
This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+22.37%
3 Year Est. Return
+53.91%
5 Year Est. Return
10 Year Est. Return
AUM
$208M
AUM Growth
-$32.9M
Cap. Flow
-$25.7M
Cap. Flow %
-12.33%
Top 10 Hldgs %
100%
Holding
63
New
1
Increased
4
Reduced
5
Closed
53
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUAL icon
1
iShares MSCI USA Quality Factor ETF
QUAL
$46.1B
$58.2M 27.96%
326,910
-10,562
-3% -$1.92M
QQQ icon
2
Invesco QQQ Trust
QQQ
$466B
$42.8M 20.57%
83,798
-4,351
-5% -$2.2M
IQLT icon
3
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
$36.8M 17.66%
990,439
-35,851
-3% -$1.4M
EFV icon
4
iShares MSCI EAFE Value ETF
EFV
$26B
$21.2M 10.19%
404,248
+5,062
+1% +$277K
VTV icon
5
Vanguard Value ETF
VTV
$186B
$16.5M 7.92%
97,398
+768
+0.8% +$135K
XLP icon
6
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$13.1M 6.27%
166,161
+894
+0.5% +$72.6K
IGV icon
7
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
$7.8M 3.75%
+77,909
New +$7.72M
EWU icon
8
iShares MSCI United Kingdom ETF
EWU
$4.02B
$3.96M 1.9%
116,688
-92,656
-44% -$3.3M
XLU icon
9
State Street Utilities Select Sector SPDR ETF
XLU
$23.5B
$3.95M 1.9%
104,494
+614
+0.6% +$24.4K
EWJ icon
10
iShares MSCI Japan ETF
EWJ
$21.5B
$3.94M 1.89%
58,649
-49,985
-46% -$3.45M
ALEC icon
11
Alector
ALEC
$167M
-14,708
Closed -$68.5K
ALT icon
12
CALL
Altimmune
ALT
$558M
-26,200
Closed -$161K
ALT icon
13
PUT
Altimmune
ALT
$558M
-23,500
Closed -$144K
AMGN icon
14
CALL
Amgen
AMGN
$198B
-2,000
Closed -$644K
AMGN icon
15
PUT
Amgen
AMGN
$198B
-2,000
Closed -$644K
APGE icon
16
Apogee Therapeutics
APGE
$10.1B
-5,240
Closed -$308K
APLS
17
CALL
DELISTED
Apellis Pharmaceuticals
APLS
-13,100
Closed -$378K
APLT
18
CALL
DELISTED
Applied Therapeutics
APLT
-20,300
Closed -$173K
ARGX icon
19
argenx
ARGX
$53.8B
-953
Closed -$517K
ASND icon
20
Ascendis Pharma A/S
ASND
$17.1B
-4,585
Closed -$685K
AVDL
21
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-26,200
Closed -$344K
AZN icon
22
CALL
AstraZeneca
AZN
$262B
-32,000
Closed -$4.99M
BCRX icon
23
CALL
BioCryst Pharmaceuticals
BCRX
$2.36B
-13,100
Closed -$99.6K
BMY icon
24
Bristol-Myers Squibb
BMY
$124B
-17,785
Closed -$920K
BPMC
25
DELISTED
Blueprint Medicines
BPMC
-2,618
Closed -$242K

Similar funds

Valence8 US's Q4 2024 Portfolio in Review

As of Q4 2024, Valence8 US held 63 positions worth $208M, down 14% from $241M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Valence8 US withdrew a net $25.7M in Q4 2024, closing 53 positions and reducing 5 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $999K position sold in full.

By sector, the portfolio is most concentrated in Financials at 0% of assets, down from 0.02% a quarter earlier, followed by Healthcare.

Against the trend, Valence8 US opened a new position in iShares Expanded Tech-Software Sector ETF worth $7.8M.

  • Valence8 US's largest Q4 2024 buy was iShares Expanded Tech-Software Sector ETF: 77,909 shares worth $7.8M.
  • Valence8 US added most to iShares MSCI EAFE Value ETF in Q4 2024, an estimated $277K increase.
  • Valence8 US's biggest Q4 2024 reduction was iShares MSCI Japan ETF, cutting an estimated $3.45M.
  • Valence8 US fully exited Jazz Pharmaceuticals in Q4 2024, selling an estimated $999K.
  • Valence8 US's ten largest holdings make up 100% of its $208M portfolio in Q4 2024.
  • Valence8 US opened 1 new position and closed 53 in Q4 2024.
  • Valence8 US's portfolio value fell 14% quarter-over-quarter to $208M.

Based on Valence8 US's 13F filing for Q4 2024, filed 12 Feb 2025.